• Accelerating TB vaccine Research & Development through partnership
  • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Steering Committee
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
      • Policies
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Access to services
      • MTBVAC in Newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • MTBVACN3
        • Work packages
        • Governance
        • The consortium and its partners
        • Publications and news
        • Acknowledgement
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project overview and achievements
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 other publications
      • For funders
        • TBVI R&D priorities and funding opportunities
        • TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News
    • Contact us:

    Archives

    Monthly Archive for: "October, 2021"
    Home / 2021 / October
      0
    By Marit Holleman
    In Uncategorized Posted October 28, 2021

    Global TB Report 2021

    The WHO published the Global TB Report 2021. This report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the [...]

    Read More
      0
    By Marit Holleman
    In Uncategorized Posted October 28, 2021

    Invest in new TB vaccines to save millions of lives

    New TB vaccines are on the horizon, but their success is not guaranteed. World leaders pledged to deliver at least USD $2 billion annually for TB research, including vaccines, at the 2018 United [...]

    Read More
      0
    By Marit Holleman
    In Uncategorized Posted October 18, 2021

    The STriTuVaD Consortium announces the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for TB

    The STriTuVaD Consortium is proud to announce the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for Tuberculosis (TB).  Please read the press release

    Read More
      0
    By Cora Agterdenbosch
    In Uncategorized Posted October 11, 2021

    Pipeline Report 2021

    2021 Pipeline Report Tuberculosis Vaccines

    Read More
      0
    By Marit Holleman
    In Uncategorized Posted October 1, 2021

    Meeting Report Global Forum on TB Vaccines 2021

    From 20-22 April 2021 the virtual Global Forum on Tuberculosis (TB) Vaccines took place. Please read the meeting report.  

    Read More
    Load More
    Menu
    • Home
    • About us
    • What we do
    • How we work
    • For researchers and vaccine developers
    • For funders
    • Pipeline of vaccines
    • News
    TuBerculosis Vaccine Initiative (TBVI)

    Runderweg 6
    8219 PK Lelystad
    The Netherlands
    Email: info@tbvi.eu
    Phone: +31 320 277 550

    © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

    Start typing and press Enter to search

    Cookies

    This website uses cookies that help the website function

    OK No